AltAssets is the private equity news and research service from Almeida Capital
AltAssets HomeAlmeida Capital websiteAlmeida Capital

 

PRINT THIS PAGE

Lessons learned: How the biotech industry grew up

17/06/2004Source: Wellington Partners.  

The biotech industry in Europe is celebrating its comeback with a new entrepreneurial mindset. What used to be a science-driven sector has now emerged as a product-based industry, according to Wellington Partners.

Never losing sight of their objectives or their costs, biotech vendors are pushing the development of their own products and looking for strong market partners early on.

Click here to view the full report (pdf 300kb)

You need Adobe Acrobat to read this document. If you do not have it, you can download it free from www.adobe.com/products/acrobat/readstep.html

Wellington Partners invests venture capital in young and creative information and communication technology and life science companies that embrace, create and utlise global technology trends.

top of the page

  Advanced Search

HOME | ABOUT US | CONTRIBUTE | FAQ | ADVERTISING | RSS FEED | WEEKLY NEWSLETTER SIGN-UP | CONTACT US

All rights reserved. This document and its content are for your personal, non-commercial use only. No further copying, reproduction, distribution, transmission, display of AltAssets content is allowed. To obtain permission please contact editorial@altassets.com. You may not alter or remove the copyright or any other statements from copies of the content.

AltAssets is a service offered by Almeida Capital's Research Division. Available online at www.AltAssets.net
Almeida Capital Ltd is regulated by FSA and registered in England (no. 3945728). Registered Office: Acre House, 11-15 William Road, London NW1 3ER. Legals & Terms of Use
Content is © AltAssets 2000-2008

Subscribe to our newsletter Subscribe to our newsletter